Insulin Delivery Devices Market Size, Share, and Trends 2026 to 2035

Insulin Delivery Devices Market Size and Growth 2026 to 2035

The global insulin delivery devices market size is valued at USD 21.13 billion in 2025 and is predicted to increase from USD 22.50 billion in 2026 to approximately USD 39.12 billion by 2035, expanding at a CAGR of 6.35% from 2026 to 2035.

Key Takeaways

• North America led the global market with the highest market share of 31% in 2025.
• By product, the insulin pen segment has held the largest market share of 38% in 2025.
• By end user, the home care segment captured the biggest revenue share of 50% in 2025.
• By distribution channel, the incident delivery devices segment registered the maximum market share in 2025.

What are Insulin Delivery Devices?

The continuing rapid growth of the global insulin delivery devices market is attributed to the increasing number of people diagnosed with diabetes globally, greater education surrounding early intervention in disease progression, and continual technological advancements that are being developed rapidly. The development of insulin pen devices, pumps, or continuous subcutaneous insulin infusion (CSII), as well as smart insulin delivery system technology, is significantly improving patient convenience and therefore enhancing the rate at which patients adhere to their insulin therapy regimen.

The increasing demand for efficient, easy-to-use devices that provide accurate and reliable delivery of insulin via a minimally invasive method in the patient's home has led to the acceleration of the growth of this emerging market segment, which is becoming an integral part of modern-day diabetes management.

There are many ways in order to administer insulin to a patient. It is a hormone that helps in regulating the blood sugar levels of the diabetic patients. This hormone can be administered by the way of pens, pumps, jet sprays and syringes. The growing prevalence of diabetes is an important factor for the growth of the market. It also happens to be a major reason for surging mortality rate. It's about 1.5 million deaths due to diabetes in 2019 according to the report of the World Health Organization. The diabetic patients use the available insulin delivery devices in order to access the insulin dose which helps in regulating the hormone by maintaining the blood sugar of the patient. Administering insulin in the form of up tablet is also not possible as it gets degenerated by the digestive enzymes . Therefore there are a wide range of devices that are used in order to deliver the insulin at the correct location.

During the pandemic the patients with comorbidity contracted the disease earlier. About 40% of the hospitals has diabetic patients suffering with COVID-19. There were disruptions in the supply chain, shipping delays and shut down of various manufacturing units.

Growth Factors

The increasing prevalence of diabetes which is mainly due to obesity, aging or unhealthy lifestyle is expected to help in the growth of the market. Obesity happens to be the major factor causing diabetes. The number of diabetic patients across the world is increasing mainly in the obese or overweight patients. The diabetes off lifted population in the nations is driving the market for the insulin delivery devices. There's an increased demand for these devices due to various innovations. As an increasing expenditure on diabetes care the market for the insulin delivery devices is expected to grow. Due to the favorable reimbursement policies another option of other facilitative initiatives are helping in the growth of the market. The progressive and the chronic nature of diabetes inflicts the use of insulin over a long period of time. The pandemic has also proven to be a great factor in the expansion of insulin delivery devices market. As the population afflicted with diabetes across the globe is increasing it is driving the market for the Insulin delivery devices.

Insulin Delivery Devices Market Outlook

• Industry Growth Overview: The growth of the industry has been fueled by an increased incidence of diabetes, technological advancements, and an increased preference for using self-administered devices to administer insulin. The emergence and continuing improvement of smart connected insulin delivery systems will play a significant role in future growth opportunities.
• Sustainability Trends: Companies that manufacture insulin delivery devices have begun to focus on using sustainable materials, creating reusable insulin delivery pens, and reducing their plastic footprint. Products that use sustainable packaging and extend the lifespan of the devices are expected to be valued by consumers more than those that do not.
• Global Expansion: The emerging economies will be a focus for the continued growth of the insulin delivery device industry as manufacturers expand their manufacturing, distribution, and pricing strategies to take advantage of the growing populations of people with diabetes not being served.
• Startup Ecosystem: Startups are driving innovative ideas in the area of insulin delivery devices with the introduction of artificial intelligence-powered insulin pumps, digital tracking of doses, and designs that are focused on the needs of patients. Collaborations between established companies and startups are accelerating the commercialization and entry into the marketplace of new insulin delivery devices.

MarketScope

Insulin Delivery Devices Market Segment Insights

[[segment_insights]]

Insulin Delivery Devices Market Regional Insights

[[regional_insights]]

Insulin Delivery Devices Market Value Chain Analysis

[[value_chain]]

Insulin Delivery Devices Market Companies

• Novo Nordisk A/S
• Wockhardt Ltd.
• Medtronic
• F. Hoffmann-La Roche, Ltd.
• Abbott Laboratories
• Sanofi
• Eli Lilly and Company
• Biocon Ltd.
• Ypsomed AG
• Becton, Dickinson and Company

Insulin Delivery Devices Market Segment Covered in Report

[[segment_covered]]